Clinical Trial Update: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

View source ↗

Summary

A real-world study reports on the use of mogamulizumab for treating cutaneous T-cell lymphoma and its subtypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Mogamulizumab (mogamulizumab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Status: COMPLETED